Prognostic impact of EMT (epithelial-mesenchymal-transition)-related protein expression in endometrial cancer

References

• Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol 2006; 20:207 - 25; http://dx.doi.org/10.1016/j.bpobgyn.2005.10.007; PMID: 16359925
   PubMed Web of Science ®Google Scholar
• Kadar N, Homesley HD, Malfetano JH. Prognostic factors in surgical stage III and IV carcinoma of the endometrium. Obstet Gynecol 1994; 84:983 - 6; PMID: 7970482
   PubMed Web of Science ®Google Scholar
• Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 1991; 40:55 - 65; http://dx.doi.org/10.1016/0090-8258(91)90086-K; PMID: 1989916
   PubMed Web of Science ®Google Scholar
• Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002; 2:563 - 72; http://dx.doi.org/10.1038/nrc865; PMID: 12154349
   PubMed Web of Science ®Google Scholar
• Woodhouse EC, Chuaqui RF, Liotta LA. General mechanisms of metastasis. Cancer 1997; 80:Suppl 1529 - 37; http://dx.doi.org/10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F; PMID: 9362419
   PubMed Web of Science ®Google Scholar
• Sivridis E, Giatromanolaki A, Gatter KC, Harris AL, Koukourakis MI, Tumor and Angiogenesis Research Group. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma. Cancer 2002; 95:1055 - 63; http://dx.doi.org/10.1002/cncr.10774; PMID: 12209691
   PubMed Web of Science ®Google Scholar
• Inoue M. Current molecular aspects of the carcinogenesis of the uterine endometrium. Int J Gynecol Cancer 2001; 11:339 - 48; http://dx.doi.org/10.1046/j.1525-1438.2001.01046.x; PMID: 11737463
   PubMed Web of Science ®Google Scholar
• Fanning J, Brown S, Phibbs G, Kramer T, Zaher A. Immunohistochemical evaluation is not prognostic for recurrence in fully staged high-risk endometrial cancer. Int J Gynecol Cancer 2002; 12:286 - 9; http://dx.doi.org/10.1046/j.1525-1438.2002.t01-1-01103.x; PMID: 12060450
   PubMed Web of Science ®Google Scholar
• Salvesen HB, Das S, Akslen LA. Loss of nuclear p16 protein expression is not associated with promoter methylation but defines a subgroup of aggressive endometrial carcinomas with poor prognosis. Clin Cancer Res 2000; 6:153 - 9; PMID: 10656444
   PubMed Web of Science ®Google Scholar
• Salvesen HB, Stefansson I, Kalvenes MB, Das S, Akslen LA. Loss of PTEN expression is associated with metastatic disease in patients with endometrial carcinoma. Cancer 2002; 94:2185 - 91; http://dx.doi.org/10.1002/cncr.10434; PMID: 12001116
   PubMed Web of Science ®Google Scholar
• Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7:131 - 42; http://dx.doi.org/10.1038/nrm1835; PMID: 16493418
   PubMed Web of Science ®Google Scholar
• Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED, et al. Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression. J Cell Physiol 2007; 213:374 - 83; http://dx.doi.org/10.1002/jcp.21223; PMID: 17680632
   PubMed Web of Science ®Google Scholar
• Yang J, Weinberg RA. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 2008; 14:818 - 29; http://dx.doi.org/10.1016/j.devcel.2008.05.009; PMID: 18539112
   PubMed Web of Science ®Google Scholar
• Baum B, Settleman J, Quinlan MP. Transitions between epithelial and mesenchymal states in development and disease. Semin Cell Dev Biol 2008; 19:294 - 308; http://dx.doi.org/10.1016/j.semcdb.2008.02.001; PMID: 18343170
   PubMed Web of Science ®Google Scholar
• Grünert S, Jechlinger M, Beug H. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat Rev Mol Cell Biol 2003; 4:657 - 65; http://dx.doi.org/10.1038/nrm1175; PMID: 12923528
   PubMed Web of Science ®Google Scholar
• Huber MA, Kraut N, Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005; 17:548 - 58; http://dx.doi.org/10.1016/j.ceb.2005.08.001; PMID: 16098727
   PubMed Web of Science ®Google Scholar
• Nieto MA. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 2002; 3:155 - 66; http://dx.doi.org/10.1038/nrm757; PMID: 11994736
   PubMed Web of Science ®Google Scholar
• Hemavathy K, Ashraf SI, Ip YT. Snail/slug family of repressors: slowly going into the fast lane of development and cancer. Gene 2000; 257:1 - 12; http://dx.doi.org/10.1016/S0378-1119(00)00371-1; PMID: 11054563
   PubMed Web of Science ®Google Scholar
• Grau Y, Carteret C, Simpson P. Mutations and Chromosomal Rearrangements Affecting the Expression of Snail, a Gene Involved in Embryonic Patterning in DROSOPHILA MELANOGASTER. Genetics 1984; 108:347 - 60; PMID: 17246230
   PubMed Web of Science ®Google Scholar
• Valdés F, Alvarez AM, Locascio A, Vega S, Herrera B, Fernández M, et al. The epithelial mesenchymal transition confers resistance to the apoptotic effects of transforming growth factor Beta in fetal rat hepatocytes. Mol Cancer Res 2002; 1:68 - 78; PMID: 12496370
   PubMed Web of Science ®Google Scholar
• Pérez-Losada J, Sánchez-Martín M, Pérez-Caro M, Pérez-Mancera PA, Sánchez-García I. The radioresistance biological function of the SCF/kit signaling pathway is mediated by the zinc-finger transcription factor Slug. Oncogene 2003; 22:4205 - 11; http://dx.doi.org/10.1038/sj.onc.1206467; PMID: 12833143
   PubMed Web of Science ®Google Scholar
• Vega S, Morales AV, Ocaña OH, Valdés F, Fabregat I, Nieto MA. Snail blocks the cell cycle and confers resistance to cell death. Genes Dev 2004; 18:1131 - 43; http://dx.doi.org/10.1101/gad.294104; PMID: 15155580
   PubMed Web of Science ®Google Scholar
• Takeichi M. Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 1993; 5:806 - 11; http://dx.doi.org/10.1016/0955-0674(93)90029-P; PMID: 8240824
   PubMed Web of Science ®Google Scholar
• Wijnhoven BP, Dinjens WN, Pignatelli M. E-cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg 2000; 87:992 - 1005; http://dx.doi.org/10.1046/j.1365-2168.2000.01513.x; PMID: 10931041
   PubMed Web of Science ®Google Scholar
• Sakuragi N, Nishiya M, Ikeda K, Ohkouch T, Furth EE, Hareyama H, et al. Decreased E-cadherin expression in endometrial carcinoma is associated with tumor dedifferentiation and deep myometrial invasion. Gynecol Oncol 1994; 53:183 - 9; http://dx.doi.org/10.1006/gyno.1994.1113; PMID: 8188077
   PubMed Web of Science ®Google Scholar
• Cheng L, Nagabhushan M, Pretlow TP, Amini SB, Pretlow TG. Expression of E-cadherin in primary and metastatic prostate cancer. Am J Pathol 1996; 148:1375 - 80; PMID: 8623909
   PubMed Web of Science ®Google Scholar
• Bremnes RM, Veve R, Gabrielson E, Hirsch FR, Baron A, Bemis L, et al. High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer. J Clin Oncol 2002; 20:2417 - 28; http://dx.doi.org/10.1200/JCO.2002.08.159; PMID: 12011119
   PubMed Web of Science ®Google Scholar
• Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrard DF, et al. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 1995; 55:5195 - 9; PMID: 7585573
   PubMed Web of Science ®Google Scholar
• Yoshiura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T, Hirohashi S. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci USA 1995; 92:7416 - 9; http://dx.doi.org/10.1073/pnas.92.16.7416; PMID: 7543680
   PubMed Web of Science ®Google Scholar
• Grooteclaes ML, Frisch SM. Evidence for a function of CtBP in epithelial gene regulation and anoikis. Oncogene 2000; 19:3823 - 8; http://dx.doi.org/10.1038/sj.onc.1203721; PMID: 10949939
   PubMed Web of Science ®Google Scholar
• Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E, et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 2001; 7:1267 - 78; http://dx.doi.org/10.1016/S1097-2765(01)00260-X; PMID: 11430829
   PubMed Web of Science ®Google Scholar
• Blanco MJ, Moreno-Bueno G, Sarrio D, Locascio A, Cano A, Palacios J, et al. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene 2002; 21:3241 - 6; http://dx.doi.org/10.1038/sj.onc.1205416; PMID: 12082640
   PubMed Web of Science ®Google Scholar
• Grille SJ, Bellacosa A, Upson J, Klein-Szanto AJ, van Roy F, Lee-Kwon W, et al. The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 2003; 63:2172 - 8; PMID: 12727836
   PubMed Web of Science ®Google Scholar
• Hajra KM, Chen DY, Fearon ER. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 2002; 62:1613 - 8; PMID: 11912130
   PubMed Web of Science ®Google Scholar
• Sugimachi K, Tanaka S, Kameyama T, Taguchi K, Aishima S, Shimada M, et al. Transcriptional repressor snail and progression of human hepatocellular carcinoma. Clin Cancer Res 2003; 9:2657 - 64; PMID: 12855644
   PubMed Web of Science ®Google Scholar
• Batlle E, Sancho E, Francí C, Domínguez D, Monfar M, Baulida J, et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000; 2:84 - 9; http://dx.doi.org/10.1038/35000034; PMID: 10655587
   PubMed Web of Science ®Google Scholar
• Blechschmidt K, Sassen S, Schmalfeldt B, Schuster T, Höfler H, Becker KF. The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients. Br J Cancer 2008; 98:489 - 95; http://dx.doi.org/10.1038/sj.bjc.6604115; PMID: 18026186
   PubMed Web of Science ®Google Scholar
• Tuhkanen H, Soini Y, Kosma VM, Anttila M, Sironen R, Hämäläinen K, et al. Nuclear expression of Snail1 in borderline and malignant epithelial ovarian tumours is associated with tumour progression. BMC Cancer 2009; 9:289; http://dx.doi.org/10.1186/1471-2407-9-289; PMID: 19695091
   PubMed Web of Science ®Google Scholar
• Kurrey NK, K A, Bapat SA. Snail and Slug are major determinants of ovarian cancer invasiveness at the transcription level. Gynecol Oncol 2005; 97:155 - 65; http://dx.doi.org/10.1016/j.ygyno.2004.12.043; PMID: 15790452
   PubMed Web of Science ®Google Scholar
• Elloul S, Elstrand MB, Nesland JM, Tropé CG, Kvalheim G, Goldberg I, et al. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Cancer 2005; 103:1631 - 43; http://dx.doi.org/10.1002/cncr.20946; PMID: 15742334
   PubMed Web of Science ®Google Scholar
• Yilmaz M, Christofori G, Lehembre F. Distinct mechanisms of tumor invasion and metastasis. Trends Mol Med 2007; 13:535 - 41; http://dx.doi.org/10.1016/j.molmed.2007.10.004; PMID: 17981506
   PubMed Web of Science ®Google Scholar
• Coppola D, Fu L, Nicosia SV, Kounelis S, Jones M. Prognostic significance of p53, bcl-2, vimentin, and S100 protein-positive Langerhans cells in endometrial carcinoma. Hum Pathol 1998; 29:455 - 62; http://dx.doi.org/10.1016/S0046-8177(98)90060-0; PMID: 9596268
   PubMed Web of Science ®Google Scholar
• Cano A, Pérez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000; 2:76 - 83; http://dx.doi.org/10.1038/35000025; PMID: 10655586
   PubMed Web of Science ®Google Scholar
• Alves CC, Carneiro F, Hoefler H, Becker KF. Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers. Front Biosci 2009; 14:3035 - 50; http://dx.doi.org/10.2741/3433; PMID: 19273255
   PubMed Web of Science ®Google Scholar
• Shih JY, Tsai MF, Chang TH, Chang YL, Yuan A, Yu CJ, et al. Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma. Clin Cancer Res 2005; 11:8070 - 8; http://dx.doi.org/10.1158/1078-0432.CCR-05-0687; PMID: 16299238
   PubMed Web of Science ®Google Scholar
• Shioiri M, Shida T, Koda K, Oda K, Seike K, Nishimura M, et al. Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients. Br J Cancer 2006; 94:1816 - 22; http://dx.doi.org/10.1038/sj.bjc.6603193; PMID: 16773075
   PubMed Web of Science ®Google Scholar
• Bolós V, Peinado H, Pérez-Moreno MA, Fraga MF, Esteller M, Cano A. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci 2003; 116:499 - 511; http://dx.doi.org/10.1242/jcs.00224; PMID: 12508111
   PubMed Web of Science ®Google Scholar
• Kurrey NK, Jalgaonkar SP, Joglekar AV, Ghanate AD, Chaskar PD, Doiphode RY, et al. Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem Cells 2009; 27:2059 - 68; http://dx.doi.org/10.1002/stem.154; PMID: 19544473
   PubMed Web of Science ®Google Scholar
• Bhat-Nakshatri P, Appaiah H, Ballas C, Pick-Franke P, Goulet R Jr., Badve S, et al. SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype. BMC Cancer 2010; 10:411; http://dx.doi.org/10.1186/1471-2407-10-411; PMID: 20691079
   PubMed Web of Science ®Google Scholar